Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy

Steven A Muller, Alessio Gasperetti, Laurens P Bosman, Amand F Schmidt, Annette F Baas, Ahmad S Amin, Arjan C Houweling, Arthur A M Wilde, Paolo Compagnucci, Mattia Targetti, Michela Casella, Leonardo Calò, Claudio Tondo, Pim van der Harst, Folkert W Asselbergs, J Peter van Tintelen, Marish I F J Oerlemans, Anneline S J M Te Riele

Research output: Contribution to journalArticleAcademicpeer-review


BACKGROUND: Clinical guidelines recommend regular screening for arrhythmogenic right ventricular cardiomyopathy (ARVC) to monitor at-risk relatives, resulting in a significant burden on clinical resources. Prioritizing relatives on their probability of developing definite ARVC may provide more efficient patient care.

OBJECTIVES: The aim of this study was to determine the predictors and probability of ARVC development over time among at-risk relatives.

METHODS: A total of 136 relatives (46% men, median age 25.5 years [IQR: 15.8-44.4 years]) from the Netherlands Arrhythmogenic Cardiomyopathy Registry without definite ARVC by 2010 task force criteria were included. Phenotype was ascertained using electrocardiography, Holter monitoring, and cardiac imaging. Subjects were divided into groups with "possible ARVC" (only genetic or familial predisposition) and "borderline ARVC" (1 minor task force criterion plus genetic or familial predisposition). Cox regression was performed to determine predictors and multistate modeling to assess the probability of ARVC development. Results were replicated in an unrelated Italian cohort (57% men, median age 37.0 years [IQR: 25.4-50.4 years]).

RESULTS: At baseline, 93 subjects (68%) had possible ARVC, and 43 (32%) had borderline ARVC. Follow-up was available for 123 relatives (90%). After 8.1 years (IQR: 4.2-11.4 years), 41 (33%) had developed definite ARVC. Independent of baseline phenotype, symptomatic subjects (P = 0.014) and those 20 to 30 years of age (P = 0.002) had a higher hazard of developing definite ARVC. Furthermore, patients with borderline ARVC had a higher probability of developing definite ARVC compared with those with possible ARVC (1-year probability 13% vs 0.6%, 3-year probability 35% vs 5%; P < 0.01). External replication showed comparable results (P > 0.05).

CONCLUSIONS: Symptomatic relatives, those 20 to 30 years of age, and those with borderline ARVC have a higher probability of developing definite ARVC. These patients may benefit from more frequent follow-up, while others may be monitored less often.

Original languageEnglish
Pages (from-to)214-225
Number of pages12
JournalJournal of the American College of Cardiology
Issue number3
Publication statusPublished - 18 Jul 2023


  • ARVC
  • family screening
  • predictors
  • screening interval
  • ventricular arrhythmia


Dive into the research topics of 'Individualized Family Screening for Arrhythmogenic Right Ventricular Cardiomyopathy'. Together they form a unique fingerprint.

Cite this